Lymphangiogenesis in gastric cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis.
about
Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneumComparative effectiveness and safety between oxaliplatin-based and cisplatin-based therapy in advanced gastric cancer: A meta-analysis of randomized controlled trials.Brain-derived neurotrophic factor promotes VEGF-C-dependent lymphangiogenesis by suppressing miR-624-3p in human chondrosarcoma cells.The Gene Expression Status of the PI3K/AKT/mTOR Pathway in Gastric Cancer Tissues and Cell Lines.CircRNA_100269 is downregulated in gastric cancer and suppresses tumor cell growth by targeting miR-630.Celastrol induces cell cycle arrest by MicroRNA-21-mTOR-mediated inhibition p27 protein degradation in gastric cancer.Fucoidan inhibits lymphangiogenesis by downregulating the expression of VEGFR3 and PROX1 in human lymphatic endothelial cells.Knockdown of HMGN5 increases the chemosensitivity of human urothelial bladder cancer cells to cisplatin by targeting PI3K/Akt signaling.MicroRNA-1 inhibits tumorigenicity of esophageal squamous cell carcinoma and enhances sensitivity to gefitinib.A meta-analysis of the lymphatic microvessel density and survival in gastric cancer with 1809 cases.SCARA5 plays a critical role in the progression and metastasis of breast cancer by inactivating the ERK1/2, STAT3, and AKT signaling pathways.Regulation by FSH of the dynamic expression of retinol-binding protein 4 in the mouse ovary.Annexin A5 regulates hepatocarcinoma malignancy via CRKI/II-DOCK180-RAC1 integrin and MEK-ERK pathways.
P2860
Q28073129-8E417E9F-2ED5-4489-8CCD-A8D0DCACD4BBQ33432145-78608052-F3C0-429B-94F3-353C1EB07630Q38695820-27453B21-C3EF-440E-905D-36DAA490A6EEQ38772498-D6CDA452-E5CE-439B-9AA5-5648D310CADAQ41008499-33AEEF09-375D-40DB-8253-50610F835302Q42061952-EE63E699-8D65-4871-8CE3-9C584E51D4E5Q42363709-4FD5CB40-28FF-487E-AAC4-95D2E3A7DCC3Q45792633-51D6C01C-8285-4589-9A8B-67DE0D657376Q48513587-ED62A6B9-E435-415A-86AF-D1BADA98B3FBQ49494210-6B13C998-43A1-4DC0-A579-288EAE493F04Q51006788-B800A1CB-1EE8-4FC4-8939-9657199D3BE4Q54120350-6EE3D3DE-1354-4907-B0D2-FDDC29F881C5Q55003973-D175AA9B-8293-44D1-B6E5-D836D7DCFBEF
P2860
Lymphangiogenesis in gastric cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Lymphangiogenesis in gastric cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis.
@ast
Lymphangiogenesis in gastric cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis.
@en
type
label
Lymphangiogenesis in gastric cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis.
@ast
Lymphangiogenesis in gastric cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis.
@en
prefLabel
Lymphangiogenesis in gastric cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis.
@ast
Lymphangiogenesis in gastric cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis.
@en
P2093
P2860
P1433
P1476
Lymphangiogenesis in gastric cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis.
@en
P2093
Changyan Chen
Hongxia Chen
Hongyuan Chen
Jianyong Chen
Runnian Guan
Xiaodong Zhou
Xiaolong Qi
P2860
P2888
P356
10.1186/S12885-015-1109-0
P407
P577
2015-03-07T00:00:00Z
P5875
P6179
1046852424